Both in Pharmaceuticals
Wave Life Sciences vs Geron
Over the past year WVE returned −52.0% and GERN returned −24.3%; their daily moves had a correlation of -0.00.
WVE −52.0% GERN −24.3%Growth of $1, one year, split-adjusted
| Metric | WVE | GERN |
|---|---|---|
| Price | $3.64 | $0.9830 |
| Market cap | $717.9M | $631.6M |
| Today | +5.51% | −14.52% |
| 1 month | 0.0% | −20.7% |
| 6 months | −48.4% | −34.9% |
| Year to date | −78.6% | −25.5% |
| 1 year | −52.2% | −23.2% |
| Revenue growth (YoY) | +72.9% | +17.2% |
| Gross margin | 100.0% | 83.9% |
| Net margin | −470.5% | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | 10.1× | 3.1× |
| Net cash | $430.7M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 63.0% | 71.2% |
| Short % of float | 17.0% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).